← All stocks

EyePoint, Inc.

EYPT Net selling

CIK 0001314102 #3169 in the set updated 18 Sep 2026

Bought (12 mo)

$71.98K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.04M

$182.54K on a plan · $917.17K straight out of an exercise

Sold at will

$942.24K

1 of 11 sales

Net

−$1.97M

−$870.26K against sales at will

By person

7 insiders · 13 transactions

1.3×

Jay Duker holds only 1.3 times base salary in stock. $922.03K of shares against $696.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Jay Duker last reported holding, valued at $4.93, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ribeiro Ramiro

Chief Medical Officer

—

$948.77K (7) scheduled

−$948.77K

0.0000%

$0.00

−100.0%

Cormorant Asset Management, LP entity

Former 10% Owner

—

$942.24K (1)

−$942.24K

8,265,000

9.59%

$40.75M

−0.7%

Lurker Nancy

Director

—

$150.94K (3) scheduled

−$150.94K

294,346

0.3414%

$1.45M

+201.5%

Zaderej Karen L.

Director

$52.26K (1)

—

+$52.26K

49,100

0.0570%

$242.06K

+197.6%

Duker Jay S.

President and CEO

$19.72K (1)

—

+$19.72K

187,025

0.2169%

$922.03K

+36.3%

Elston George

Chief Financial Officer

—

97,470

0.1131%

$480.53K

+254.2%

Landis John B.

Director

—

21,400

0.0248%

$105.50K

+87.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Zaderej Karen L.

18 Aug 2026

Director

Buy

10,600

$4.93

$52.26K

Duker Jay S.

16 Mar 2026

President and CEO

Buy indirect

1,500

$13.15

$19.72K

Show all 13 transactions →

What was left out

Form 4 filings counted 32

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 6

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 773,532

History held since 4 Nov 2016